|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Lymphedema | |||||
| Breast | |||||
| Cancer | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Breast Neoplasms | |||||
| 3 | More general conditions related to this trial | ||||
| Breast Diseases | |||||
| Lymphatic Diseases | |||||
| Neoplasms | |||||
| Neoplasms by Site | |||||
| Skin Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| Pycnogenol | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Pycnogenols | |||||
| 6 | More general drug interventions related to this trial | ||||
| Adjuvants, Immunologic | |||||
| Hematologic Agents | |||||
| Immunologic Factors | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Platelet Aggregation Inhibitors | |||||
| Therapeutic Uses | |||||
| 7 | Sponsors listed in this trial | ||||
| National Center for Complementary and Alternative Medicine (NCCAM) | |||||